R. Jian

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.

M. Kazatchkine, C. Piketty, A. Landau, 2000, AIDS.

Long-term ef®cacy of combination therapy with interferon-á2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

P. Brunevalb, A. Landau, R. Jian, 2001 .

Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy.

M. Kazatchkine, P. Bruneval, M. Bélair, 2003, American journal of clinical pathology.

Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

M. Kazatchkine, P. Bruneval, L. Bélec, 2001 .

Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients.

M. Kazatchkine, P. Bruneval, L. Bélec, 2001, AIDS.

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

R. Jian, P. Rougier, P. Ruszniewski, 1996, Gut.